ArticleAdvances in patient-reported outcomes2025
Brief report: Relationships of frailty and age with nonresponse to patient reported outcome measures.
Article in Advances in patient-reported outcomes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Preoperative single-dose systemic steroid in major head and neck surgery (J-SUPPORT 2002, PreSte-HN Study): a phase III, placebo-controlled, randomized, double-blind study.International journal of clinical oncology · 2026Trial
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Patient-reported outcome measures are increasingly being used to evaluate health care interventions and systems, including in surgery. Simultaneously, older adults comprise a greater proportion of patients undergoing surgery. Frailty, a clinical syndrome more prevalent among older adults has not been examined as a factor associated with PROM response. In this single center retrospective analysis, we sought to understand the association between age and frailty with response to PROMs among a pilot group of patients. We find that within this sample of patients, adults between 66 and 84 and those with prefrailty were more likely to respond than patients less than 65 and those who are robust, respectively.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.